These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20846104)

  • 1. The relationship between aminoterminal propeptide of type III procollagen and heart rate variability parameters in heart failure patients: a potential serum marker to evaluate cardiac autonomic control and sudden cardiac death.
    Lin YH; Lin C; Lo MT; Lin HJ; Wu YW; Hsu RB; Chao CL; Hsu HC; Wang PC; Wu VC; Wang SS; Lee CM; Chien KL; Ho YL; Chen MF; Peng CK
    Clin Chem Lab Med; 2010 Dec; 48(12):1821-7. PubMed ID: 20846104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients.
    Lin YH; Lin LY; Wu YW; Chien KL; Lee CM; Hsu RB; Chao CL; Wang SS; Hsein YC; Liao LC; Ho YL; Chen MF
    Clin Chim Acta; 2009 Nov; 409(1-2):96-9. PubMed ID: 19747906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in autonomic control of heart rate after ischemic cerebral stroke].
    Lakusić N; Mahović D; Babić T; Sporis D
    Acta Med Croatica; 2003; 57(4):269-73. PubMed ID: 14639860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between serum fibrosis markers and restrictive ventricular filling in patients with heart failure with reduced ejection fraction: A technetium-99m radionuclide ventriculography study.
    Lin YT; Lin YH; Wu XM; Ko CL; Yen RF; Chen YH; Hsu RB; Lee CM; Wang SS; Chen MF; Wu YW
    Oncotarget; 2017 Jan; 8(2):2381-2390. PubMed ID: 27924061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum markers of deranged myocardial collagen turnover: their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure.
    Flevari P; Theodorakis G; Leftheriotis D; Kroupis C; Kolokathis F; Dima K; Anastasiou-Nana M; Kremastinos D
    Am Heart J; 2012 Oct; 164(4):530-7. PubMed ID: 23067911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomic markers and cardiovascular and arrhythmic events in heart failure patients: still a place in prognostication? Data from the GISSI-HF trial.
    La Rovere MT; Pinna GD; Maestri R; Barlera S; Bernardinangeli M; Veniani M; Nicolosi GL; Marchioli R; Tavazzi L;
    Eur J Heart Fail; 2012 Dec; 14(12):1410-9. PubMed ID: 22851700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure.
    Kaye DM; Khammy O; Mariani J; Maeder MT
    Eur J Heart Fail; 2013 Mar; 15(3):292-8. PubMed ID: 23143794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction.
    de Denus S; Lavoie J; Ducharme A; O'Meara E; Racine N; Sirois MG; Neagoe PE; Zhu L; Rouleau JL; White M
    Can J Cardiol; 2012; 28(1):62-8. PubMed ID: 22104539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover.
    Martos R; Baugh J; Ledwidge M; O'Loughlin C; Murphy NF; Conlon C; Patle A; Donnelly SC; McDonald K
    Eur J Heart Fail; 2009 Feb; 11(2):191-7. PubMed ID: 19168518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart rhythms, ventricular arrhythmias, and death in chronic heart failure.
    Ponikowski P; Anker SD; Amadi A; Chua TP; Cerquetani E; Ondusova D; O'Sullivan C; Adamopoulos S; Piepoli M; Coats AJ
    J Card Fail; 1996 Sep; 2(3):177-83. PubMed ID: 8891855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time and frequency domain analyses of heart rate variability in patients with epilepsy.
    Evrengül H; Tanriverdi H; Dursunoglu D; Kaftan A; Kuru O; Unlu U; Kilic M
    Epilepsy Res; 2005 Feb; 63(2-3):131-9. PubMed ID: 15777689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants.
    Ulrich D; Lichtenegger F; Eblenkamp M; Repper D; Pallua N
    Plast Reconstr Surg; 2004 Jul; 114(1):229-36. PubMed ID: 15220598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cross-sectional study of relation between blood pressure and heart rate variability in patients with peritoneal dialysis].
    Li LX; Tang W; Chen BJ; Wang T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Dec; 43(6):849-54. PubMed ID: 22178833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial.
    Lopez-Andrès N; Rossignol P; Iraqi W; Fay R; Nuée J; Ghio S; Cleland JG; Zannad F; Lacolley P
    Eur J Heart Fail; 2012 Jan; 14(1):74-81. PubMed ID: 22089058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure.
    Cicoira M; Rossi A; Bonapace S; Zanolla L; Golia G; Franceschini L; Caruso B; Marino PN; Zardini P
    J Card Fail; 2004 Oct; 10(5):403-11. PubMed ID: 15470651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis.
    Lebedev DA; Lyasnikova EA; Vasilyeva EY; Babenko AY; Shlyakhto EV
    J Diabetes Res; 2020; 2020():6976153. PubMed ID: 33224989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Ponikowski P; Anker SD; Chua TP; Szelemej R; Piepoli M; Adamopoulos S; Webb-Peploe K; Harrington D; Banasiak W; Wrabec K; Coats AJ
    Am J Cardiol; 1997 Jun; 79(12):1645-50. PubMed ID: 9202356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison the prognostic value of galectin-3 and serum markers of cardiac extracellular matrix turnover in patients with chronic systolic heart failure.
    Chang YY; Chen A; Wu XM; Hsu TP; Liu LY; Chen YH; Wu YW; Lin HJ; Hsu RB; Lee CM; Wang SS; Lo MT; Chen MF; Lin YH
    Int J Med Sci; 2014; 11(11):1098-106. PubMed ID: 25170292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF.
    Zile MR; O'Meara E; Claggett B; Prescott MF; Solomon SD; Swedberg K; Packer M; McMurray JJV; Shi V; Lefkowitz M; Rouleau J
    J Am Coll Cardiol; 2019 Feb; 73(7):795-806. PubMed ID: 30784673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of coronary angioplasty on heart rate variability explored in the domain of time and frequency in patients with one-vessel coronary disease].
    Petretta M; Marciano F; Migaux ML; Salemme L; Themistoclakis S; Esposito N; Carpinelli A; Apicella C; Piscione F; Bonaduce D
    G Ital Cardiol; 1994 Aug; 24(8):973-84. PubMed ID: 7958639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.